Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Jul 2019 for Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.), €17k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Mark McKenna: trading record in brief
Mark McKenna appears in our data through filings on Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) shares, published by SEDI. The record holds 9 filings, for trades running from 2 August 2018 to 24 June 2019.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 23 July 2019 came the latest disclosure, an option exercise for €42k in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Filings reach the SEDI feed a median of 5 days after the trade. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark McKenna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
1,190 shares@ CA$21.256.4% of flowCommon SharesTSXSEDI:3401602
2,986 shares@ CA$21.2515.9% of flowCommon SharesTSXSEDI:3401601
4,235 shares@ CA$23.8225.7% of flowCommon SharesTSXSEDI:3388572
1,913 shares@ CA$23.8211.6% of flowCommon SharesTSXSEDI:3388573
2,176 shares@ CA$23.5113.0% of flowCommon SharesTSXSEDI:3366006
746 shares@ CA$23.514.5% of flowCommon SharesTSXSEDI:3366009
974 shares@ CA$23.565.8% of flowCommon SharesTSXSEDI:3334812
2,841 shares@ CA$23.5617.0% of flowCommon SharesTSXSEDI:3334810
Common SharesTSXSEDI:3225368
9 of 9 declarations
